Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14
08:00am, Wednesday, 07'th Aug 2024
GARDEN CITY, NY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting second quarter 2024 financial results on a virtual conference call ho
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
08:00am, Thursday, 11'th Jul 2024
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Crea
ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript
04:47pm, Thursday, 09'th May 2024
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q1 2024 Earnings Conference Call May 9, 2024 11:00 AM ET Company Participants Noella Alexander-Young - Renmark Financial Communications Ted Karkus - Chief Executive
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Thursday, 02'nd May 2024
ProPhase Labs (PRPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
08:00am, Thursday, 25'th Apr 2024
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap
ProPhase Labs Unveils Project ZenQ-AI
08:00am, Tuesday, 16'th Apr 2024
Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development.
PRISM MarketView – Biotech Breakfast
08:29am, Monday, 15'th Apr 2024
Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 – PRISM MarketView – Healthcare equitie
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
08:00am, Wednesday, 10'th Apr 2024
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today report
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09:00pm, Monday, 01'st Apr 2024
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biopharma, genomics, and diagnostics company, today anno
ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript
05:45pm, Friday, 15'th Mar 2024
ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid re
Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230%
02:43pm, Tuesday, 12'th Mar 2024
In the volatile world of trading and investing, where fortunes can be made or lost in the blink of an eye, two companies caught the attention of Wall Street despite their recent struggles over the las
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
08:00am, Friday, 08'th Mar 2024
GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call hosted
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
08:00am, Wednesday, 14'th Feb 2024
Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotec
